MEG3 overexpression of the inactivated PI3K/Akt signaling pathway can inhibit the growth of cervical cancer HeLa cells and breast cancer cells, thus achieving anticancer effects (Wang et al., 2017; Zhu et al., 2019). Here, MEG3 is linked to breast carcinoma.